piwik-script

English Intern
Lehrstuhl für klinische Epidemiologie und Biometrie

Dr. Kirsten Haas

kurzer Lebenslauf

2014 Promotion zur Dr. phil. (magna cum laude), TU Dortmund
seit 2013    Wissenschaftliche Mitarbeiterin, Institut für Klinische Epidemiologie und Biometrie, Universität Würzburg
2009-2013 Wissenschaftliche Mitarbeiterin, Bundesanstalt für Arbeitsschutz und Arbeitsmedizin, Arbeitsgruppe "Mentale Gesundheit und Kognitive Leistungsfähigkeit", Berlin
2000-2008 Leiterin Qualitätsmanagement QuaSi-Niere gGmbH, Berlin
1999-2000 Wissenschaftliche Mitarbeiterin TU Chemnitz, Leiterin Forschungsstelle für Regionale Gesundheitsförderung, Chemnitz
1998-1999 freie wissenschaftliche Mitarbeiterin Bundesgesundheitssurvey 1998, Robert-Koch-Institut, Berlin  
1995-1998 Postgraduiertenstudiengang "Public Health", TU Berlin, Abschluss MPH
1987-1993 Studium Ökotrophologie, Fachrichtung Ernährungswissenschaften, Christian-Albrechts-Universität Kiel, Abschluss Diplom

wissenschaftliche Schwerpunkte

Registerarbeit, Qualitätsmanagement, Evaluation

Hauptpublikationen der letzten Jahre

2024[ to top ]
  • 1.
    Schutzmeier M, Brandstetter LS, Stangl S, Ahnert J, Grau A, Gerken L, et al. Development and pilot-testing of an evidence-based quality indicator set for home mechanical ventilation care: the OVER-BEAS project. BMC Health Services Research [Internet]. 2024;24(1):152. Available from: https://doi.org/10.1186/s12913-024-10583-2
2023[ to top ]
  • 1.
    Hebestreit H, Lapstich AM, Brandstetter L, Krauth C, Deckert J, Haas K, et al. Effect of the addition of a mental health specialist for evaluation of undiagnosed patients in centres for rare diseases (ZSE-DUO): a prospective, controlled trial with a two-phase cohort design. EClinicalMedicine. 2023;65:102260.
  • 1.
    Tilch K, Hopff SM, Appel K, Kraus M, Lorenz-Depiereux B, Pilgram L, et al. Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany. BMC Med Ethics. 2023;24(1):84.
  • 1.
    Herrmann J, Müller K, Notz Q, Hübsch M, Haas K, Horn A, et al. Prospective single-center study of health-related quality of life after COVID-19 in ICU and non-ICU patients. Sci Rep. 2023;13(1):6785.
  • 1.
    Horn A, Stangl S, Parisi S, Bauer N, Roll J, Löffler C, et al. Systematic review with meta-analysis: Stress-management interventions for patients with irritable bowel syndrome. Stress Health. 2023;.
  • 1.
    Skazel T, Raub M, Haas K, Schutzmeier M, Brandstetter L, Ahnert J, et al. Die notärztliche Versorgung von langzeitbeatmeten Patienten im außerstationären Umfeld – im Spannungsfeld zwischen Intensivmedizin und häuslicher Versorgung. NOTARZT. 2023;.
  • 1.
    Klingshirn H, Gerken L, Hofmann K, Heuschmann PU, Haas K, Schutzmeier M, et al. [Complexity of outpatient intensive care for ventilated people: Cross-mapping into the standardised NNN-taxonomy]. Pflege. 2023;36(5):259-68.
  • 1.
    Kippnich M, Skazel T, Klingshirn H, Gerken L, Heuschmann P, Haas K, et al. [Analysis of the weaning process in intensive care patients with regard to documentation and transfer to further treatment units]. Med Klin Intensivmed Notfmed. 2023;118(4):269-76.
2022[ to top ]
  • 1.
    Nielsen PB, Melgaard L, Overvad TF, Jensen M, Larsen TB, Lip GYH. Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study. Stroke. 2022;53(8):2559-68.
  • 1.
    Kippnich M, Skazel T, Klingshirn H, Gerken L, Heuschmann P, Haas K, et al. Analyse des Weaningprozesses bei Intensivpatienten im Hinblick auf Dokumentation und Verlegung in weiterbehandelnde Einheiten [Analysis of the weaning process in intensive care patients with regard to documentation and transfer to further treatment units]. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 2022;118.
  • 1.
    Klingshirn H, Gerken L, Hofmann K, Heuschmann PU, Haas K, Schutzmeier M, et al. Komplexität außerstationärer Intensivpflege beatmeter Menschen [Complexity of outpatient intensive care for ventilated people: Cross-mapping into the standardised NNN-taxonomy]. Pflege [Internet]. 2022;:null. Available from: https://econtent.hogrefe.com/doi/abs/10.1024/1012-5302/a000919
  • 1.
    Hebestreit H, Zeidler C, Schippers C, de Zwaan M, Deckert J, Heuschmann P, et al. Dual guidance structure for evaluation of patients with unclear diagnosis in centers for rare diseases (ZSE-DUO): study protocol for a controlled multi-center cohort study. Orphanet Journal of Rare Diseases [Internet]. 2022;17(1):47. Available from: https://doi.org/10.1186/s13023-022-02176-1
  • 1.
    Herrmann J, Lotz C, Karagiannidis C, Weber-Carstens S, Kluge S, Putensen C, et al. Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation. Crit Care. 2022;26(1):190.
  • 1.
    Klingshirn H, Gerken L, Hofmann K, Heuschmann PU, Haas K, Schutzmeier M, et al. Comparing the quality of care for long-term ventilated individuals at home versus in shared living communities: a convergent parallel mixed-methods study. BMC Nursing [Internet]. 2022;21(1):224. Available from: https://doi.org/10.1186/s12912-022-00986-z
  • 1.
    Appel KS, Maier D, Hopff SM, Mitrov L, Stecher M, Scherer M, et al. 1886. External Validation of the 4C Mortality Score and the qSOFA for Different Variants of Concerns of SARS-CoV-2 Using Data of the NAPKON Cross-Sectoral Cohort Platform (SUEP). Open Forum Infectious Diseases [Internet]. 2022;9(Supplement_2). Available from: https://doi.org/10.1093/ofid/ofac492.1513
2021[ to top ]
  • 1.
    Horn A, Krist L, Lieb W, Montellano FA, Kohls M, Haas K, et al. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021;49(6):1277-8.
  • 1.
    Klingshirn H, Gerken L, Hofmann K, Heuschmann PU, Haas K, Schutzmeier M, et al. How to improve the quality of care for people on home mechanical ventilation from the perspective of healthcare professionals: a qualitative study. BMC Health Services Research [Internet]. 2021;21(1):774. Available from: https://doi.org/10.1186/s12913-021-06743-3
  • 1.
    Skazel T, Kippnich M, Klingshirn H, Gerken L, Heuschmann P, Haas K, et al. [Ventilation Patients between Acute Care and Long-term Out-of-Hospital Ventilation - Routine Documentation based Analysis of the Care Situation]. Pneumologie. 2021;.
2020[ to top ]
  • 1.
    Stangl S, Haas K, Eichner FA, Grau A, Selig U, Ludwig T, et al. Development and proof-of-concept of a multicenter, patient-centered cancer registry for breast cancer patients with metastatic disease—the “Breast cancer care for patients with metastatic disease” (BRE-4-MED) registry. Pilot and Feasibility Studies [Internet]. 2020;6(1):11. Available from: https://doi.org/10.1186/s40814-019-0541-3
  • 1.
    Haas K, Rücker V, Hermanek P, Misselwitz B, Berger K, Seidel G, et al. Association Between Adherence to Quality Indicators and 7-Day In-Hospital Mortality After Acute Ischemic Stroke. Stroke [Internet]. 2020;51(12):3664-72. Available from: https://www.ahajournals.org/doi/abs/10.1161/STROKEAHA.120.029968
  • 1.
    Stangl S, Haas K, Eggers C, Reese JP, Tönges L, Volkmann J. Versorgung von Parkinson-Patienten in Deutschland. Der Nervenarzt [Internet]. 2020;91(6):493-502. Available from: https://doi.org/10.1007/s00115-020-00890-4
2019[ to top ]
  • 1.
    Haas K, Purrucker JC, Rizos T, Heuschmann PU, Veltkamp R. Rationale and design of the Registry of Acute Stroke Under Novel Oral Anticoagulants-prime (RASUNOA-prime). Eur Stroke J. 2019;4(2):181-8.
  • 1.
    Wiegering V, Keupp A, Frietsch M, Fiessler C, Haas K, Haubitz I, et al. Role of B cells in chronic graft-versus-host disease after allogeneic stem cell transplantation in children and adolescents. Br J Haematol. 2019;186(5):e133-e137.
  • 1.
    Haas K, Stangl S, Steigerwald F, Matthies C, Gruber D, Kühn AA, et al. Development of evidence-based quality indicators for deep brain stimulation in patients with Parkinson’s disease and first year experience of implementation of a nation-wide registry. Parkinsonism & Related Disorders [Internet]. 2019;60:3-9. Available from: https://www.sciencedirect.com/science/article/pii/S1353802019300161
2018[ to top ]
  • 1.
    Purrucker JC, Wolf M, Haas K, Siedler T, Rizos T, Khan S, et al. Microbleeds in ischemic vs hemorrhagic strokes on novel oral anticoagulants. Acta Neurol Scand. 2018;138(2):163-9.
2017[ to top ]
  • 1.
    Purrucker JC, Rizos T, Haas K, Wolf M, Khan S, Heuschmann PU, et al. Coagulation Testing in Intracerebral Hemorrhage Related to Non-vitamin K Antagonist Oral Anticoagulants. Neurocrit Care. 2017;27(2):208-13.
  • 1.
    Purrucker JC, Haas K, Wolf M, Rizos T, Khan S, Kraft P, et al. Haemorrhagic Transformation after Ischaemic Stroke in Patients Taking Non-vitamin K Antagonist Oral Anticoagulants. J Stroke. 2017;19(1):67-76.
  • 1.
    Dietz UA, Fleischhacker A, Menzel S, Klinge U, Jurowich C, Haas K, et al. Risk-adjusted procedure tailoring leads to uniformly low complication rates in ventral and incisional hernia repair: a propensity score analysis and internal validation of classification criteria. Hernia. 2017;21(4):569-82.
2016[ to top ]
  • 1.
    Purrucker JC, Haas K, Rizos T, Khan S, Poli S, Kraft P, et al. Coagulation Testing in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants. Stroke. 2016;48(1):152-8.
  • 1.
    Purrucker JC, Haas K, Rizos T, Khan S, Wolf M, Hennerici MG, et al. Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants. JAMA Neurol. 2016;73(2):169-77.
  • 1.
    Purrucker JC, Wolf M, Haas K, Rizos T, Khan S, Dziewas R, et al. Safety of Endovascular Thrombectomy in Patients Receiving Non-Vitamin K Antagonist Oral Anticoagulants. Stroke. 2016;47(4):1127-30.